Gamma-hydroxybutyrate treatment of schizophrenia: a pilot study.
摘要：
Gamma-hydroxybutyrate (GHB) was administered to seven chronic schizophrenic patients in the first double-blind, placebo-replacement trial of this compound. No significant drug effect in this group was obtained. Two patients became nonpsychotic during the drug trial, three got worse and two patients did not respond. The two patients who responded with improvement were augmenters, as measured by average evoked potential (EP), had low platelet MAO activity and high cerebrospinal fluid (CSF) homovanillic acid (HVA). A number of patients developed akathisia and dystonia during the trial, especially after receiving probenecid for lumbar puncture. Further study is warranted, possibly in a selected patient group.
展开
关键词：
Humans Recurrence Hydroxybutyrates Sodium Oxybate Pilot Projects Double-Blind Method Drug Evaluation Schizophrenia Female Male
DOI：
10.1055/s-2007-1019583
被引量：
年份：
1981
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
来源期刊
引用走势
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
